Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series

This is a retrospective study extending over a period of three years concerning patients with gastric adenocarcinoma hospitalized in the digestive cancer surgery and liver transplant service of the IBN ROCHD University Hospital Center in Casablanca. Evaluation from a series of 80 cases of gastric adenocarcinomas, follow-up to determine the prognostic factors influencing mortality, morbidity and survival.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gastric Cancer Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Mortality of Gastric Cancer Neoplasms Neoplasms by Site Overall Survival of Patients With Gastric Cancer Stomach Diseases Stomach Neoplasms

Age range

15 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with gastric cancer

Exclusion criteria

patients with benign tumors or other pathologies requiring gastric resection

Treatment and study plan

Total or subtotal gastrectomy

Procedure

Gastric resection with digestive continuity according Roux or Bilroth

Other names: Adjuvent chemotherapy

Primary outcomes

Overall survival

Time frame: 30 months

An overall survival of patients treated for gastric cancer

Sponsors and collaborators

Lead sponsor

Sylvestre KABURA

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Jan 11, 2022
Registry last updated: Jan 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed